Published in Women's Health Weekly, October 5th, 2006
Study 1: The use of continuous administration of bupivicaine after axillary lymph node dissection (ALND) significantly decreases pain and opioid analgesic requirements.
According to a study from the United States, "Although considered a safe surgical procedure, ALND is associated with postoperative numbness, paresthesias, pain, and muscle weakness. Despite meticulous surgical technique and the absence of long thoracic or thoracodorsal nerve injury, the risk of these complications are reported as great as 35 to 50%, with a subset of patients developing chronic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.